The independent source for health policy research, polling, and news.
721 - 740 of 1,300 Results
Illegal medications, sold in immigrant communities around the United States, can cause serious harm to consumers, authorities say. Law enforcement officers are cracking down, but some think more must be done.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Nearly 2 million more Americans were uninsured in 2018 than in the previous year, according to the Census Bureau鈥檚 annual report. Plus, the Trump administration announced plans to ban flavored vape liquids, and Congress is back and working to address high prescription drug prices and 鈥渟urprise鈥 medical bills. This week, Joanne Kenen of Politico, Tami Luhby of CNN and Rebecca Adams of CQ Roll Call join KHN鈥檚 Julie Rovner to discuss these issues and more.
In the first six months of this year, pharmaceutical firms and their trade groups donated almost $4 million to the campaigns of a variety of senators and House members.
Almost 80% of Americans support efforts in Congress to protect patients from bills that come from doctors or hospitals that were outside their insurance network.
So far this year, 33 states have enacted more than 50 measures to address drug prices, affordability and access. Congress is eyeing the efforts to see what works.
KHN's Sarah Varney discussed opioid painkillers in India with NPR's Rachel Martin on "Morning Edition" Thursday.
New research published in JAMA Network Open quantified for the first time international differences in doctors鈥 prescribing habits and patients鈥 use of these highly addictive painkillers.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Germany鈥檚 pharmacies provide insights into the country鈥檚 low drug prices and strict regulations. But they鈥檙e still businesses.
As the Indian government reluctantly loosens its prescription opioid laws after decades of lobbying by palliative care advocates desperate to ease their patients鈥 pain, the nation鈥檚 sprawling, cash-fed health care system is ripe for misuse.
What began in India as a populist movement to bring inexpensive morphine to the diseased and dying poor has paved the way for a booming pain management industry. Now, new customers are being funneled to U.S. drugmakers bedeviled by a government crackdown back home.
Congress has a variety of reforms in mind that could roil the drugmaking business and potentially slash prices.
The state judge ruled that drugmaker Johnson & Johnson contributed to the opioid epidemic that has claimed the lives of 6,000 Oklahomans.
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don't have to.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Before 鈥淢edicare for All,鈥 there was just Medicare, the federal program that provides insurance to 60 million Americans. This week, KHN鈥檚 Julie Rovner talks to Tricia Neuman of the Kaiser Family Foundation about how Medicare works and whom it serves. Then, Joanne Kenen of Politico, Paige Winfield Cunningham of The Washington Post and Kimberly Leonard of the Washington Examiner join Rovner to talk about some current Medicare issues being debated in Washington, D.C.
Americans routinely skirt federal law by crossing into Canada and Mexico or tapping online pharmacies abroad to purchase prescription medications at a fraction of the price they would pay at home. Is it safe? Not necessarily. Here鈥檚 some advice.
MDMA, the psychoactive ingredient in the club drug known as molly or ecstasy, is being tested in combination with therapy as a treatment for severe trauma.
It can be difficult to get a prescription for buprenorphine, one of the gold standards for treating opioid use disorder. And not all pharmacies stock the drug.
漏 2026 KFF